Hellebore

Other Names

American helleboreAmerican white helleboreBear's footBearsfootBlack helleboreBugbaneChriste HerbeChristmas flowerChristmas roseCorn lilyCorsican helleboreDungwortEaster roseElleboreElleborinElleborumElleborusEuropean white helleboreFalse helleboreFalse skunk cabbageGargut rootGreen helleboreHe-barfootHelleborasterHelleboraster foetidusHelleboraster viridisHelleboraster viridis (L.) MoenchhelléborosHelleborusHelleborus abchasicusHelleborus angustifoliusHelleborus argutifoliusHelleborus atrorubensHelleborus beugesiacusHelleborus brevicaulisHelleborus caucasicusHelleborus chinensisHelleborus cyclophyllosHelleborus deflexifoliusHelleborus dumetorumHelleborus foetidusHelleborus hunfalvyanus var. viridisHelleborus hyemalisHelleborus kochiiHelleborus lividusHelleborus multifidusHelleborus nigerHelleborus niger majorHelleborus occidentalisHelleborus odorusHelleborus officinalisHelleborus orientalisHelleborus pallidusHelleborus personatiHelleborus polychromusHelleborus purpurascensHelleborus ranunculinusHelleborus thibetanusHelleborus torquatusHelleborus trifoliusHelleborus vesicariusHelleborus viridisIndian pokeItch weedItchweedLenten helleboreLenten roseMelampodeMelampodiumNieswurzOracle flowerOracle roseOriental helleboreSetterSetterwortSnow roseStinking helleboreStinkwortSwamp helleboreVeratrum albumVeratrum helleborasterVeratrum nigrumVeratrum virideWhite helleboreWinter helleboreWinter roseἑλλέβορος

Synopsis

Hellebore: A Comprehensive Encyclopedic Reference

1. Identity and Botanical Overview

1.1 The Name "Hellebore" and Its Taxonomic Complexity

The common name "hellebore" was applied by the ancient Greeks to two botanically unrelated plants: black hellebore, belonging to the buttercup family Ranunculaceae and identified as Helleborus niger (the Christmas rose), and white hellebore, a member of the lily family, Liliaceae (now reclassified into Melanthiaceae). The common name "hellebore" is first attested in the 1300s, originating via Old French and Latin from Ancient Greek helléboros. This terminological ambiguity has created persistent confusion in both historical and modern literature, with phytochemists, toxicologists, and historians sometimes treating the two plant lineages interchangeably when they are chemically and botanically distinct.

In the early days of medicine, two kinds of hellebore were recognized: black hellebore, which included various species of Helleborus, and white hellebore (now known as Veratrum album, or "false hellebore"), which belongs to a different plant family, the Melanthiaceae. The true and false hellebores bear no physical resemblance to one another, but they do share the same poisonous and purgative properties. Medieval and Renaissance herbalists continued to group V. album and V. nigrum with the true hellebores.

1.2 True Hellebore: Genus Helleborus (Ranunculaceae)

Helleborus belongs to the Ranunculaceae family and is distributed in southeastern Europe and western Asia. The genus comprises approximately 20 species. One of the most studied members, Helleborus niger L., is commonly called the Christmas rose — a flowering evergreen perennial cultivated in ornamental gardens.

Key species within the genus include:

Helleborus niger L. — Black hellebore / Christmas rose. The most historically prominent medicinal species, native to mountainous regions of central and southern Europe.
Helleborus viridis — Green hellebore. Found wild in many parts of England, especially on limestone soil; the latter has injurious effects on cattle if eaten by them.
Helleborus foetidus — Stinking hellebore / Bearsfoot. H. viridis (green hellebore) and H. foetidus (stinking hellebore) cause poisoning similar to that of H. niger.
Helleborus purpurascens — Purple hellebore, characteristic of the Carpathian area and the Balkans, with a distinct ethnomedicinal tradition in Romania.
Helleborus odorus subsp. cyclophyllus — Fragrant hellebore, the principal plant used in ancient Greek medicine and studied for antiseizure activity.
Helleborus thibetanus — A plant endemic to China, known as "Tigencao" or "Xiao-tao-er-qi," mainly distributed in Sichuan, Gansu and Shaanxi provinces, whose roots and rhizomes are commonly used as folk medicine to treat asthma, cystitis, sores and traumatic injury.

1.3 False Hellebore: Genus Veratrum (Melanthiaceae)

Veratrum album, Veratrum nigrum, and Veratrum viride are still known respectively as "white hellebore," "black hellebore," and "green hellebore." Among the most important of these for indigenous peoples is Veratrum viride (skookum root, green false hellebore, Indian poke, Indian hellebore), one of the most important medicinal plants for indigenous peoples throughout British Columbia. The Veratrum species contain a distinct and very different set of alkaloids from true Helleborus and are treated separately in this article where chemistry permits, though historical accounts frequently conflate them.

1.4 Common Forms and Preparations

Across cultures and time periods, hellebore has been prepared in multiple forms:

Decoctions and infusions of dried root or rhizome, the most widely documented traditional form.
Tinctures: It is used in the form of a tincture, and must be administered with great care. The American Homeopathic Pharmacopoeia of 1883 describes chopping and pounding the fresh root into a pulp, followed by the addition of alcohol for an eight-day soak, then decanting and filtering to produce the final tincture.
Powders and snuffs: White hellebore was occasionally used as an errhine or sternutatory, diluted with starch or other mild powder, in cases of amaurosis and chronic affections.
Ointments and decoctions for external use: It is occasionally used in the form of an ointment or decoction in obstinate skin diseases such as scabies, or to kill lice, but even this use is not free from danger.
Vinous tincture: A vinous tincture was advocated in early 19th-century medical writing as the preferred internal form of white hellebore, being convenient for administration and least likely to produce alarming effects.
Fermented aqueous extract: In modern preclinical research, a fermented aqueous extract of H. niger (designated HNE) has been evaluated as a standardized preparation.
Homeopathic preparations: Samuel Hahnemann (1755–1843) reported H. niger as a remedy to treat depression, lethargy and sleepiness. Homeopathic preparations of Helleborus niger are commercially available in dilutions ranging from 5CH to 1000K.
Insecticide: The dried and powdered root was used as an insecticide both in distributed applications and as an additive to laundry water to rid clothing of lice.

2. Traditional and Historical Use

2.1 Ancient Greek and Roman Medicine

According to Pliny, black hellebore was used as a purgative in mania by Melampus, a soothsayer and physician, 1,400 years before Christ — hence the name Melampodium applied to hellebores. Of the three principal species, black hellebore has the most distinguished lineage, having been used by the Greek physician Hippocrates primarily as a purgative.

In the Hippocratic Collection, both black and white hellebore together account for the highest number of mentions of all plants used medicinally in the entire Collection. They have no major difference in the range of pathologies they treat, except some skin conditions for which black hellebore was indicated in external use. Both hellebores were characterized as cathartic and were used for a great many conditions that needed elimination of a pathogenic matter — particularly one of the four physiological liquids (blood, phlegm, yellow bile, and black bile) believed to reside in the body.

The conditions requiring administration in internal use were mostly gynaecological, from emmenagogue to abortifacient, particularly the evacuation of any physiological substance in the uterus and on the cervix. In the 1st century CE, in Dioscorides' vast encyclopaedia De materia medica, black and white hellebore are clearly distinguished in both their description and their medicinal uses. Documentation of Helleborus niger dates back to the 2nd century CE in Dioscorides' De Materia Medica, where it was prescribed for "melancholic and phrenetic" conditions — treatments for mania and severe mental afflictions.

The Roman natural historian Pliny records that black hellebore, identified with H. niger, was used as a fumigant in the ritual purification of houses as well as the magical protection of cattle. Pliny includes an extended discussion of the medicinal uses of both black hellebore and another plant he calls "white hellebore," and evidently members of the genus Helleborus and species in the genus Veratrum were used interchangeably in ancient medicine.

2.2 Humoural Medicine and the Theory Underlying Use

The rationale for hellebore's extensive medical use grew from the theory of the four humours, which became highly influential in medicine in Ancient Greece and Rome and continued to shape how illness was viewed and treated in Europe throughout the medieval period and into the early modern period. Although the idea of the body containing humours is thought to pre-date Hippocrates (460–370 BCE), he is usually credited as applying this theory to practical medicine. In this framework, four humours (blood, phlegm, yellow bile, and black bile) were believed to reside in the body, and their imbalance was thought to cause illness. Because hellebore's forceful purgative action was understood as clearing excess pathological humours, it was applied to an enormous range of diseases.

2.3 Warfare and Poisoning

Hellebore was one of the arrow drugs used by the Gauls, among other ancient groups, and it was also used to poison wells. In Roman times, V. album was used as a poison and an extract of the plant was used as an arrow tip poison; there is some thought that poisoning with V. album extract was the cause of death for Alexander the Great.

2.4 Medieval and Early Modern Europe

Medieval and Renaissance herbalists continued to group V. album and V. nigrum with the true hellebores. In the 14th-century illustrated herbal known as the Tractatus de herbis (British Library MS. Egerton 747), the true hellebore and the false hellebore are shown side by side.

Data on the medicinal use of hellebores have been recorded from ancient times until the present day; H. niger and H. viridis having been included as official drugs in earlier pharmacopoeias, such as the 2nd to 6th editions of the Austrian Pharmacopoeia. White hellebore was formerly used in cerebral affections such as mania and epilepsy, and for gout as a substitute for colchicum, often prepared as a wine of white hellebore combined with laudanum and given in doses of from half a fluid drachm to two fluid drachms.

White hellebore was used in place of colchicum for the treatment of gout, to aid in the treatment of hypertension, and to treat herpetic lesions externally, but use was limited by its toxicity. It was listed in the French pharmacopoeia as a treatment for hypertension, toxemia of pregnancy, and cardiac failure until 1982; however, current use in herbal medicines is rare, except in homeopathy.

2.5 Eastern European Ethnomedicine

Helleborus purpurascens from the Ranunculaceae family has been used as a medicinal plant in Romanian and European ethnomedicine for centuries. One of the first mentions of the therapeutic effect of this plant occurs in Diseases of Women by Hippocrates. Its use in Dacian medicine is also reported in De Materia Medica. In traditional European medicine, hellebore is used for its antimicrobial, anti-inflammatory, antitumor, cardiotonic, analgesic, antiseizure, laxative and other effects. Modern Romanian studies from the end of the 20th century demonstrated the therapeutic potential of the plant in the treatment of severe forms of rheumatism.

2.6 North American Indigenous Use

Veratrum viride (skookum root, green false hellebore, Indian poke, Indian hellebore) was one of the most important medicinal plants for indigenous peoples throughout British Columbia. Its medicinal qualities are well respected given its equally powerful ability to paralyze and kill. Appearing in the United States Pharmacopeia in 1898, it was prescribed for a wide range of conditions. In addition to traditional analgesic treatments, it was prescribed for respiratory problems ranging from pneumonia to chronic coughing and for gastrointestinal conditions such as constipation and stomachache.

2.7 Chinese Traditional Medicine (H. thibetanus)

Helleborus thibetanus, a plant endemic to China known as "Tigencao" or "Xiao-tao-er-qi," is mainly distributed in Sichuan, Gansu and Shaanxi provinces, and its roots and rhizomes are commonly used as folk medicine to treat asthma, cystitis, sores and traumatic injury.

3. Key Constituents and Active Compounds

Through reviewing recent literature, 226 compounds have been isolated and identified from the genus Helleborus. These compounds include steroids, flavonoids, phenylpropanoids, lignans, anthraquinones, phenolics and others. Among them, the main chemical constituents are steroids.

3.1 Bufadienolides

Bufadienolides are the most pharmacologically prominent compound class in Helleborus. Bufadienolides are chemically and biologically related to the cardenolides and differ from them by the presence of a δ-lactone instead of a γ-lactone ring at C-atom 17 of the steroidal ring system.

A key compound in the roots of Helleborus niger is hellebrin, a bufadienolide which has similar cardiac activity but is less toxic than the cardiac glycosides found in Digitalis and Strophanthus plants. The degradation products of hellebrin also strengthen heart contractions but are more toxic than their parent molecule. The aglycone hellebrigenin has the lowest lethal dose along with stronger cardiac activity than the original glucoside hellebrin. Though rare, hellebrin and its derivatives are considered responsible for severe or lethal Christmas rose poisonings because their interference with the ion channels of the heart can lead to various arrhythmias.

Phytochemical investigation of the whole plants of Helleborus niger L. resulted in the isolation of five undescribed compounds, including one bufadienolide, two bufadienolide rhamnosides, and two ecdysteroids, along with eight known compounds. JFCR39 panel screening suggests that the molecular target of one such bufadienolide rhamnoside is Na⁺,K⁺-ATPase.

3.2 Classical Glucosides: Helleborin and Helleborcin

Two crystalline glucosides, helleborin and helleborcin, are both powerful poisons. Helleborin has a burning, acrid taste and is narcotic; helleborcin has a sweetish taste and is a highly active cardiac poison, similar in its effects to digitalis and a drastic purgative.

3.3 Ranunculin and Protoanemonin

All plants in the buttercup family contain various cardiac glycosides as well as ranunculin, a glucoside. Ranunculin breaks down into the toxin protoanemonin in the digestive system. Protoanemonin has an unpleasant taste and can cause irritation of the skin, mucosa and eyes upon contact. If large amounts are ingested, the toxin can cause itching and blistering of the mouth and throat as well as gastroenteritis and hematemesis in both humans and animals. Due to its antibiotic effects, but also its reactivity, protoanemonin is a therapeutically and toxicologically relevant constituent, and its concentration should therefore be carefully monitored.

3.4 Steroidal Saponins

The steroid saponins, sapogenin, macranthoside I, hellebosaponin A, and hellebosaponin B, which were isolated in pure form from the rhizome and roots of H. niger, are of particular interest for broad-based biological studies. Black hellebore, in particular its constituent protoanemonin, has sporadically been suspected to induce genotoxicity, but also anti-mutagenic and even anti-leukemic properties have been reported. Though rarely occurring, many symptoms from poisoning with black hellebore described in the scientific literature can be attributed to the membranolytic properties of some steroidal saponins present in both underground and aerial parts of the plant, expressed by hemolytic activity — a potential to disintegrate the cellular membranes of red blood cells.

3.5 Ecdysteroids

Besides bufadienolides, five ecdysteroids have been described from H. niger whole plants: the new ecdysteroid (2β,3β,5β,16α)-2,3,14,16,20,25-hexahydroxycholest-7-en-6-one and the four known compounds β-ecdysone, taxisterone, stachysterone B, and shidasterone.

3.6 Flavonoids and Phenolic Compounds

Hydroalcoholic extracts of H. purpurascens have a high concentration of flavonoids, such as epicatechin, quercetin, and kaempferol. Preliminary phytochemical screening showed the presence of carbohydrate, glycoside, saponins, flavonoid, phytosterols, tannins and phenolic compounds in various extracts of roots.

3.7 MCS-18 (Macrocyclic Carbon Suboxide)

MCS-18, a macrocyclic carbon suboxide (C₃O₂)ₙ derivative, has been shown to exert immunosuppressive, immunomodulatory, and analgesic activities. MCS-18 is a macrolide derivative so far found only in H. purpurascens. Among its interesting pharmacological properties (antidiabetic, antioxidant, immunomodulatory), this compound has also demonstrated through various mechanisms several beneficial effects in inflammation-related disorders (specifically in atherosclerosis) in animal models.

3.8 Constituents of White Hellebore (Veratrum spp.)

White hellebore (Veratrum album) contains jervine, pseudo-jervine, rubijervine, veratralbine and veratrine. These steroidal alkaloids are pharmacologically distinct from the bufadienolides and saponins of true hellebore (Helleborus) and account for the characteristic toxidrome of Veratrum poisoning, which includes severe hypotension and bradycardia.

4. Mechanisms of Action

4.1 Cardiac Glycoside Activity (Na⁺/K⁺-ATPase Inhibition)

Cardiotonic bufadienolides such as hellebrin and hellebrigenin are toxic through the inhibition of the vital Na⁺/K⁺ pump (Na⁺/K⁺-ATPase), which results in an increase of intracellular calcium concentration. This mechanism is shared with digitalis glycosides and accounts for both the cardiac pharmacological activity and the toxicity of Helleborus compounds at higher doses.

4.2 Antiseizure Mechanisms

Bioassay-guided fractionation led to the isolation of a new furostanol saponin and the bufadienolide hellebrin, which both decreased PTZ-induced locomotor activity in the zebrafish epilepsy assay. Hellebrigenin, the aglycone of hellebrin, reduced the induced seizure activity more potently than the isolated compounds. To the knowledge of the investigators, the ancient and ethnopharmacological use of black hellebore as a seizure remedy was supported for the first time by modern pharmacological evidence.

4.3 Analgesic / TRPV1 Antagonism

Substance MCS-18, isolated from Helleborus purpurascens, has been shown to be a potent antagonist of the capsaicin receptor TRPV1 in rat cultured sensory neurons. TRPV1 (Transient receptor potential vanilloid 1) is a key mediator of pain signaling, and its antagonism is a recognized analgesic mechanism. H. purpurascens extracts exert a long-lasting analgesic and muscle relaxant action.

4.4 Immunomodulatory Mechanisms

The immunomodulatory effect of methanolic and hydroalcoholic hellebore extracts is not due to ecdysones and polyphenolic compounds, but to other polar substances, possibly steroid glycosides. The immunostimulatory effect of H. purpurascens has been reported in sheep; an increase in the number of lymphocytes (2×) and neutrophils (3.5×) 48 hours after injection of 5% decoction of roots and rhizomes showed improvement of the immune response in these animals.

4.5 Anticancer Mechanisms

Compounds from H. niger were evaluated for cytotoxic activity against HL-60 human leukemia cells, A549 human lung adenocarcinoma cells, SBC-3 human small-cell lung cancer cells, and TIG-3 human normal diploid cells, with IC₅₀ values ranging from 0.0016 to 6.1 μM. One bufadienolide rhamnoside exhibited potent cell proliferation inhibitory activity against SBC-3 cells after 24–48 hours of treatment and apoptosis-inducing activity via an intrinsic pathway after 72 hours of treatment.

The cytotoxic effect of H. purpurascens extracts is underpinned by the induction of apoptosis, highlighted by decreasing expression of anti-apoptotic genes (Bcl-2) and increasing expression of pro-apoptotic genes (Bad and Bax).

4.6 Membranolytic Activity of Saponins

Many symptoms from poisoning with black hellebore can be attributed to the membranolytic properties of some steroidal saponins present in both underground and aerial parts of the plant. This is expressed by hemolytic activity — a potential to disintegrate the cellular membranes of red blood cells.

5. Scientific Evidence by Area of Use

5.1 Anticancer / Antitumor Activity

Evidence type: In vitro (cell line) and preclinical — no human clinical trials reported.

In vitro investigations were performed on safety aspects of a Helleborus niger aqueous fermented extract (HNE), and its therapeutic potential against various cancer cell lines was assessed to gain insight into the respective mechanisms of action. HNE exhibited neither genotoxic nor hemolytic potential. The present investigations verified anti-angiogenetic effects on HUVEC, anti-proliferative effects, and migration-inhibiting properties on tumor cells. The lower effect of the relevant steroidal saponins compared to the whole extract underlines the fact that the whole extract is more effective than a blend of isolated pharmacologically active components.

HNE at concentrations of 600–1000 μg/ml inhibited the migration of certain cancer cells by more than 80%, including Caki-2, DLD-1, and SK-N-SH.

Compounds from H. niger showed cytotoxicity against HL-60 human leukemia cells, A549 human lung adenocarcinoma cells, and SBC-3 human small-cell lung cancer cells, with IC₅₀ values ranging from 0.0055 to 1.9 µM. HL-60 cells treated with certain compounds showed apoptosis characteristics, including nuclear chromatin condensation, accumulation of sub-G1 cells, and activation of caspase-3/7.

A hydroalcoholic extract of H. purpurascens demonstrated increased antioxidant activity, very similar to ascorbic acid, and cytotoxic effects predominantly in the breast cancer cell line, free of cytotoxic effects in healthy cell lines. Underlying the cytotoxic effect is the induction of apoptosis, highlighted by decreasing expression of anti-apoptotic genes (Bcl-2) and increasing expression of pro-apoptotic genes (Bad and Bax).

One published case report described a 64-year-old woman with epithelioid malignant pleural mesothelioma who received Helleborus niger extract alongside other complementary interventions; minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts was documented. This constitutes anecdotal evidence and cannot establish causality.

Evidence strength: Helleborus therapy is not yet supported by clinical trials in humans. The research that exists is promising but early-stage, based primarily on cell line and laboratory studies. All anticancer evidence for Helleborus remains at the in vitro and isolated case-report level as of the available literature.

5.2 Antiseizure / Neurological Activity

Evidence type: Animal model (zebrafish) — no human clinical trials reported.

Ethnopharmacological data and ancient texts support the use of black hellebore (Helleborus odorus subsp. cyclophyllus, Ranunculaceae) for the management and treatment of epilepsy in ancient Greece. A 2020 pharmacological study using bioassay-guided fractionation and a zebrafish pentylenetetrazol (PTZ)-induced seizure model demonstrated: the isolation of a new furostanol saponin and the bufadienolide hellebrin, which both decreased PTZ-induced locomotor activity. Hellebrigenin, the aglycone of hellebrin, reduced the induced seizure activity more potently than the isolated compounds. The investigators stated that this was the first time the ancient and ethnopharmacological use of black hellebore as a seizure remedy was supported by modern pharmacological evidence.

Evidence strength: Preliminary. Evidence is confined to animal (zebrafish larval) models. No human clinical data exist.

5.3 Immunomodulation

Evidence type: In vitro and animal (rodent) — no human clinical trials reported.

In vitro studies were performed using rat macrophages, murine fibroblasts and immortalized human T-lymphocytes, with viability determined by MTS assay. In vivo studies involved a rat immunodepression model. In vitro assays revealed a stronger effect of the hydroalcoholic extract on cellular proliferation compared to the methanolic extract. In the in vivo assay, the hydroalcoholic extract revealed an immunostimulatory effect in the context of experimentally induced immunosuppression with dexamethasone, a superior effect to levamisole treatment according to the same regimen, in two doses every 24 hours.

Recent research has confirmed the unique antitumor and immunomodulating activity of H. purpurascens.

Evidence strength: Preliminary. All evidence is from animal or cell-based experiments.

5.4 Anti-inflammatory and Analgesic Activity

Evidence type: Animal models and in vitro — no human clinical trials reported.

In folk medicine, Helleborus is commonly used as an anti-inflammatory and analgesic medicine for rheumatoid arthritis and bruises. A Helleborus fraction has been shown to modulate HMGB1 cytokine and attenuate septic shock in mice. Helleborus also shows antioxidant and antiproliferative activities, as well as anti-inflammatory and antinociceptive activities.

H. purpurascens extracts exert a long-lasting analgesic and muscle relaxant action. The drug "Boicil," prepared from the root extract and stems of H. purpurascens, was presented as an antialgic (analgesic), spasmolytic, and blood vessel-regulating drug with reported use in Romania for the treatment of rheumatic pains.

Evidence strength: Weak to preliminary. Evidence derives primarily from animal models and in vitro assays. No adequately powered human clinical trials are available in the peer-reviewed literature.

5.5 Antihyperglycaemic and Metabolic Effects

Evidence type: Preclinical — no human clinical trials reported.

Pharmacological studies show Helleborus has anti-hyperglycaemic properties, in addition to its other pharmacological activities. These findings, reported in a 2024 PubMed-indexed comprehensive review, are based on preclinical data. No human studies are available in the published literature.

5.6 Antibacterial Activity

Evidence type: In vitro — no human clinical trials reported.

Bufadienolides exhibit potent cytotoxic activities against cancer cells as well as antibacterial activity. Polyphenolic extracts exhibit inhibitory activity against urease and low inhibition against α-chymotrypsin and could be used in ulcer treatment.

Evidence strength: Preliminary. Confined to in vitro studies only.

5.7 Cardiovascular / Cardiac Activity

The bufadienolide hellebrin and its aglycone hellebrigenin exert digitalis-like cardiac activity through Na⁺/K⁺-ATPase inhibition. Historically, white hellebore (Veratrum album) was employed clinically for hypertension. White hellebore was used to treat hypertension, and it was listed in the French pharmacopoeia as a treatment for hypertension, toxemia of pregnancy, and cardiac failure until 1982. Modern use for cardiac conditions is obsolete due to the narrow therapeutic index and toxicity risk.

5.8 Diuretic / Renal Activity

Black hellebore possesses drastic purgative, emmenagogue and anthelmintic properties, but is violently narcotic. It was formerly much used in dropsy and amenorrhoea, and has proved of value in nervous disorders and hysteria. H. niger is related to the renal system because of its diuretic effect and its ability to support elimination of edemas through kidney activation.

6. Body Systems and Health Areas of Association

A broad pharmacological spectrum is ascribed to Christmas rose because of its multitude of compounds: anti-bacterial, anti-inflammatory, cholesterol- and blood glucose-lowering, neuroprotective, hepatoprotective and immune-modulating effects.

Nervous system: Historical use for mania, melancholy, epilepsy, depression, and hysteria; modern preclinical evidence for antiseizure activity.
Immune system: Preclinical evidence for immunostimulatory and immunomodulatory effects.
Oncology: In vitro evidence for anti-proliferative, pro-apoptotic, and anti-angiogenic activity across multiple cancer cell lines.
Cardiovascular system: Cardiac glycoside-type activity at pharmacological doses; significant toxicity risk at higher doses.
Musculoskeletal system: Traditional use for rheumatism and joint pain; modern analgesic evidence via TRPV1 antagonism.
Gastrointestinal system: Historical use as a cathartic and purgative; laxative action at medicinal doses.
Reproductive system: Historical use as an emmenagogue and abortifacient in Hippocratic medicine.
Renal system: Traditional use for dropsy (edema); preclinical diuretic activity.
Integumentary system (external): Historical use for skin conditions including scabies; documented irritant contact dermatitis from protoanemonin.

7. Dosage Forms and Reported Doses

Given the extreme toxicity of hellebore at suprapharmacological doses, the following dosages are reproduced strictly as historically or experimentally reported in cited sources, not as recommendations.

Vinous tincture (white hellebore, 19th century): An active dose of the tincture was from a half to one and a half drachms, according to the age and strength of constitution, from twelve years upwards.
Compound preparation (3 parts wine of white hellebore + 1 part laudanum, 19th century): Given in doses of from half a fluid drachm to two fluid drachms.
HNE (aqueous fermented extract, preclinical in vitro): Concentrations up to 10 µl/ml were classified as non-hemolytic. HNE at 600–1,000 μg/ml inhibited migration of certain cancer cells by more than 80%.
Antiseizure model (zebrafish): The root methanol extract showed 80% inhibition of PTZ-induced locomotor activity at 300 μg/ml.
Immunostimulation (sheep, in vivo): An increase in lymphocytes and neutrophils was shown after injection of a 5% decoction of roots and rhizomes.
Protoanemonin content in extracts: Contents of protoanemonin in a set of extract batches were 0.0896 ± 0.0125 mg/g in Helleborus extracts and 0.0230 ± 0.0076 mg/g anemonin levels, respectively.

No standardized clinical dosing regimen for Helleborus has been established in the modern peer-reviewed literature. It appeared in the United States Pharmacopeia in 1898 but has since been removed from major pharmacopoeias as a therapeutic agent due to its toxic potential.

8. Safety Considerations and Interactions

8.1 General Toxicity Profile

The plants (both black and white hellebore) are each laden with powerful chemicals that cause severe vomiting and diarrhea, muscle cramps, delirium, convulsions, asphyxia, and heart attack. Black hellebore is toxic, causing tinnitus, vertigo, stupor, thirst, a feeling of suffocation, swelling of the tongue and throat, emesis and catharsis, bradycardia (slowing of the pulse), and finally collapse and death from cardiac arrest.

8.2 Protoanemonin Toxicity

Both H. niger and H. foetidus are described as poisonous plants whose acute toxic effects are mainly due to the presence of protoanemonin as well as saponins, and possibly cardiac glycosides. Protoanemonin has an unpleasant taste and can cause irritation of the skin, mucosa and eyes upon contact. If large amounts are ingested, it can cause itching and blistering of the mouth and throat as well as gastroenteritis and hematemesis.

8.3 Cardiac Toxicity

The cardiac glycosides present are responsible for poisonings causing digitalis-like effects: bradycardia, prolonged P-R interval, idioventricular rhythm, bundle-branch block, ventricular fibrillation and asystole. Hellebrin and its derivatives are considered responsible for severe or lethal Christmas rose poisonings because their interference with the ion channels of the heart can lead to various arrhythmias.

8.4 Dermal Toxicity

The sap contains irritants like protoanemonin. Skin contact with bruised leaves or roots can cause burning and skin irritation, leading to dermatitis.

8.5 Genotoxicity Concerns (and Mitigating Data)

Two compound groups — the ranunculin derivatives including protoanemonin and the steroidal saponins — are associated with toxicity including genotoxicity and disintegration of membrane structures. However, in a 2019 study examining a fermented aqueous extract (HNE), HNE exhibited neither genotoxic nor hemolytic potential. The investigators used the Ames test and hemolytic assays to demonstrate this, suggesting that the fermentation process and extraction method may reduce genotoxic components.

8.6 Taxonomic Confusion as a Safety Concern

Some historical sources discussing the medicinal uses of hellebores did not always refer to true hellebore. As both true and false hellebores are toxic and symptoms of poisoning from false and true hellebores include vomiting and diarrhoea, the desired purgative effects for people in the past would likely be at least superficially similar but might vary in intensity depending on the type of plant used and the dosage administered. This taxonomic conflation remains a source of safety risk when non-specialist sources are consulted.

8.7 Notable Drug Interactions (Source-Documented)

Drugs such as steroids, beta-blockers, and some chemotherapy agents may interact negatively with the cardiac glycosides present in Helleborus genus plants. Calcium as an additive to IV fluids should be avoided with poisoning caused by Helleborus as calcium tends to enhance the effects of the cardiac glycosides.

8.8 White Hellebore (Veratrum) — Specific Safety Notes

White hellebore is scarcely ever used internally owing to the severity of its action. It is a violent, irritant poison. When snuffed up the nose it occasions profuse running of the nose; when swallowed, severe vomiting and profuse diarrhoea.

8.9 Historical Pharmacopoeial Discontinuation

White hellebore was listed in the French pharmacopoeia as a treatment for hypertension, toxemia of pregnancy, and cardiac failure until 1982; however, current use in herbal medicines is rare, except in homeopathy. The removal of Helleborus and Veratrum species from major Western pharmacopoeias reflects the conclusion by regulatory bodies that their risk-to-benefit ratio does not support therapeutic use in conventional medicine.

References

Health Conditions

Health conditions that Hellebore may help support.

No conditions available.

Body Systems

Body systems that Hellebore may help support.

No body systems available.